Developing and testing a new oral medication in tablet form.
SOCIETAL IS A SMALL BUSINESS CONCERN FOR DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NCGC72
['FUNDING_OTHER'] · IRISYS, INC. · NIH-11087443
This study is working on making a new tablet medication called NCGC72 and will test it in early trials to see how safe it is and how well it works for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | IRISYS, INC. (nih funded) |
| Locations | 1 site (SAN DIEGO, UNITED STATES) |
| Trial ID | NIH-11087443 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a solid oral dosage form, specifically tablets, for a new drug called NCGC72. The process involves developing the formulation, validating the methods used to analyze the drug products, and manufacturing pilot batches under Good Manufacturing Practices (GMP). Additionally, the research includes conducting a phase I clinical trial to assess the drug's safety and stability over time according to international guidelines. Patients may be involved in early-stage trials to evaluate the medication's effects.
Who could benefit from this research
Good fit: Ideal candidates for participation would be individuals who are eligible for early-stage clinical trials and meet specific health criteria for the drug being tested.
Not a fit: Patients who are not eligible for clinical trials or those with contraindications to the drug may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new oral medication that is safe and effective for patients.
How similar studies have performed: Other research in the development of oral dosage forms has shown success, indicating that this approach is well-established in the field.
Where this research is happening
SAN DIEGO, UNITED STATES
- IRISYS, INC. — SAN DIEGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GIANNINI, ROBERT — IRISYS, INC.
- Study coordinator: GIANNINI, ROBERT
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.